Metabolic hypertension: concept and practice

被引:15
作者
Zhu, Zhiming [1 ]
Wang, Peijian [1 ]
Ma, Shuangtao [2 ]
机构
[1] Third Mil Med Univ, Daping Hosp, Dept Hypertens & Endocrinol, Ctr Hypertens & Metab Dis,Chongqing Inst Hyperten, Chongqing 400042, Peoples R China
[2] PLA Chengdu Mil Area Command, Gen Hosp, Dept Cardiol, Chengdu 610083, Peoples R China
基金
中国国家自然科学基金;
关键词
hypertension; cardiometabolic risk factors; metabolic abnormalities; GLUCOSE-HOMEOSTASIS IMPLICATIONS; CARDIOVASCULAR-DISEASE RISK; BODY-MASS INDEX; INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; FOLLOW-UP; OBESITY; ACTIVATION; GENETICS; SURGERY;
D O I
10.1007/s11684-013-0264-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypertension is a serious public health problem worldwide. More than 60% of the risk factors for hypertension are associated with metabolic disturbances. Metabolic abnormalities increase the risk for hypertension and cause high blood pressure. Improving metabolic disturbances is beneficial for hypertension treatment. Due to the importance of metabolic abnormalities in the pathogenesis of hypertension, we propose a concept of metabolic hypertension. In this review, we discuss and review the clinical types, pathogenesis, risk evaluation and management of metabolic hypertension. Elucidation of the mechanism of metabolic hypertension should facilitate the design of novel pharmacotherapeutics and dedicated antihypertensive manipulations.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 59 条
  • [1] Effects of Bariatric Surgery on Cardiovascular Function
    Ashrafian, Hutan
    le Roux, Carel W.
    Darzi, Ara
    Athanasiou, Thanos
    [J]. CIRCULATION, 2008, 118 (20) : 2091 - 2102
  • [2] Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome
    Bahadir, Ozgur
    Uzunlulu, Mehmet
    Oguz, Aytekin
    Bahadir, Muzeyyen A.
    [J]. HYPERTENSION RESEARCH, 2007, 30 (01) : 49 - 53
  • [3] Bonny A, 2008, J HYPERTENS, V26, P825, DOI 10.1097/HJH.0b013e3282f857e7
  • [4] Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study
    Buyken, Anette E.
    von Eckardstein, Arnold
    Schulte, Helmut
    Cullen, Paul
    Assmann, Gerd
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 (02): : 230 - 236
  • [5] Endothelial dysfunction in obesity and insulin resistance: A road to diabetes and heart disease
    Caballero, AE
    [J]. OBESITY RESEARCH, 2003, 11 (11): : 1278 - 1289
  • [6] Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
    Cade, W. Todd
    [J]. PHYSICAL THERAPY, 2008, 88 (11): : 1322 - 1335
  • [7] Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
    Cani, P. D.
    Possemiers, S.
    Van de Wiele, T.
    Guiot, Y.
    Everard, A.
    Rottier, O.
    Geurts, L.
    Naslain, D.
    Neyrinck, A.
    Lambert, D. M.
    Muccioli, G. G.
    Delzenne, N. M.
    [J]. GUT, 2009, 58 (08) : 1091 - 1103
  • [8] The "Metabolic Memory": Is More Than Just Tight Glucose Control Necessary to Prevent Diabetic Complications?
    Ceriello, Antonio
    Ihnat, Michael A.
    Thorpe, Jessica E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) : 410 - 415
  • [9] Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases
    Cersosimo, Eugenio
    DeFronzo, Ralph A.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (06) : 423 - 436
  • [10] Chu S, 2001, Zhonghua Yi Xue Za Zhi, V81, P20